Drugs standards group nixes plan to kick pharma's crab blood habit
Horseshoe crabs' icy-blue blood is set to remain the drug industry's standard for safety tests after a powerful U.S. group ditched a plan to put on an equal footing a synthetic substitute pushed by Swiss biotech Lonza and animal welfare groups.
from Reuters: Health News https://reut.rs/3eCe0uK
https://bit.ly/2zwRqiM